A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has found a medication currently used for some blood disorders could help the ...
In practical terms, ANKIB1 sets both the timing and the intensity of the interferon response, a function the research team describes as a “molecular switch” that determines how quickly and how loudly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results